v3.25.2
Fair Value Measurements (Tables)
12 Months Ended
Jul. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Derivatives on Balance Sheet
The fair value of the Company’s derivative contracts, recorded on the Consolidated Balance Sheets, was as follows (in millions):
Assets
Liabilities
July 31,July 31,
Balance Sheet Location2025202420252024
Designated as hedging instruments
Foreign currency forward contracts
Other current assets, other current liabilities
$0.4 $0.1 $0.3 $— 
Net investment hedges
Other current assets, other long-term assets, other long-term liabilities
1.6 3.7 2.9 — 
Total designated2.0 3.8 3.2 — 
Not designated as hedging instruments
Foreign currency forward contracts
Other current assets, other current liabilities
0.9 1.0 0.4 0.3 
Total not designated0.9 1.0 0.4 0.3 
Total$2.9 $4.8 $3.6 $0.3 
Amounts related to excluded components, such as forward points, are excluded from the assessment of hedge effectiveness of net investment hedges and are expected to be reclassified into earnings throughout their maturity dates. See Note 12 for additional information on accumulated other comprehensive loss.
Schedule of Company’s Contingent Consideration Obligations
A reconciliation of the fair value of the Company’s contingent consideration liability that use unobservable inputs was as follows (in millions):
Balance as of July 31, 2024
$21.8 
Issuances1.5
Settlements
(5.8)
Adjustments to fair value(6.2)
Balance as of July 31, 2025
$11.3 
Maximum potential payout$22.5 
Balance as of July 31, 2023
$25.0 
Issuances1.0
Settlements(2.0)
Adjustments to fair value(2.2)
Balance as of July 31, 2024
$21.8 
Maximum potential payout$29.8